ANGO Stock Summary and Trading Ideas (Angiodynamics | NASDAQ:ANGO)

AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.

Angiodynamics trades on the NASDAQ stock market under the symbol ANGO.

As of February 27, 2026, ANGO stock price declined to $11.44 with 187,791 million shares trading.

ANGO has a beta of 0.58, meaning it tends to be less sensitive to market movements. ANGO has a correlation of 0.05 to the broad based SPY ETF.

ANGO has a market cap of $471.33 million. This is considered a Small Cap stock.

Last quarter Angiodynamics reported $79 million in Revenue and $.00 earnings per share. This beat revenue expectation by $3 million and exceeded earnings estimates by $.10.

In the last 3 years, ANGO traded as high as $13.99 and as low as $5.26.

The top ETF exchange traded funds that ANGO belongs to (by Net Assets): VTI, IWM, VXF, KOMP, IWN.

ANGO has outperformed the market in the last year with a price return of +21.2% while the SPY ETF gained +18.5%. However, in the short term, ANGO had mixed performance relative to the market. It has underperformed in the last 3 months, returning -7.0% vs +1.2% return in SPY. But in the last 2 weeks, ANGO shares have fared better than the market returning +4.3% compared to SPY +0.6%.

ANGO support price is $11.15 and resistance is $11.78 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ANGO shares will trade within this expected range on the day.